About News desk

This author has not yet filled in any details.
So far News desk has created 2770 blog entries.

Planar robot shows post-stroke promise

A US university has developed a new robotic platform, which utilises a patient’s brainwaves and muscle activity, to enable post-stroke rehab.

The assistive planar robot includes a closed-loop feedback system to monitor the muscle and brain activity of the user in order to trigger the execution of reach and grab in an adaptive way.

In a new paper, researchers at the University of Rhode Island Motor Control and Rehabilitation lab write: “Numerous rehabilitation approaches such as muscular electrical stimulations, brain-computer interfaces, and transcranial magnetic stimulation have been investigated to assist the affected individuals.

By |2026-09-28T21:37:38+01:009 January 2024|Stroke, Research, Smarter rehab, News, Researchers|

Could brain organoids revolutionise neuro research?

Scientists have developed 3D mini-organs from human foetal brain tissue that self-organise in vitro, presenting new possibilities for neuro research.

These lab-grown organoids open up a brand-new way of studying how the brain develops. They also offer a valuable means to study the development and treatment of diseases related to brain development, including brain tumours.

Scientists use different ways to model the biology of healthy tissue and disease in the lab. These include cell lines, laboratory animals and, since a few years, 3D mini-organs.

These so-called organoids have characteristics and a level of complexity that allows scientists to closely model the functions of an organ in the lab.

Organoids can be formed directly from cells of a tissue. Scientists can also ‘guide’ stem cells – found in embryos or in some adult tissues – to develop into the organ they aim to study.

By |2026-09-28T21:37:38+01:009 January 2024|Research, Researchers|

Hopes raised in hunt for earlier PD diagnosis

Scientists believe they may be closing in on a breakthrough in pursuit of earlier diagnosis in Parkinson’s.

In the development of Parkinson’s, the changes that will lead to neurodegeneration take place in the brain long before patients show any symptoms.

But without a test that can detect these changes, it’s difficult to intervene early to more effectively slow disease progression.

Doctors generally must rely on neurological examination and patients’ medical histories when diagnosing Parkinson’s.

Once clinical symptoms appear, however, the disease has already wreaked irreversible damage in the brain.

By |2024-07-04T17:28:54+01:009 January 2024|Parkinson's, News|

Charting new ground in post-stroke exploration

The role of immune cells in the aftermath of a stroke has been mapped out in detail in a new study.

Researchers at Weill Cornell Medicine have  catalogued the cellular response to stroke in a preclinical model, identifying the immune cells involved and the roles they may play in the days and weeks following a stroke.

During a stroke, loss of oxygen leads to brain damage and cell death. It also triggers a powerful inflammatory response in which the brain’s resident immune cells, along with cells recruited from the blood, infiltrate the injured tissue.

By |2024-07-04T17:28:54+01:009 January 2024|Stroke|

Green light for Medtronic device

Rehab tech firm Medtronic has received US FDA approval for its latest deep brain stimulation product.

Its rechargeable neurostimulator, part of the Percept RC Deep Brain Stimulation (DBS) system, has potential applications for a range of neurological conditions. The Percept range is reportedly “the only sensing-enabled DBS system on the market”, allowing the physician to personalise treatment for patients with movement disorders such as Parkinson's disease, essential tremor, and dystonia as well as epilepsy. Amaza Reitmeier, vice president and general manager, brain modulation within the Neuromodulation business, which is part of the neuroscience portfolio at Medtronic, said: "Our DBS therapy with exclusive BrainSense technology can help control debilitating tremors for people living with Parkinson's, providing patients with the ability to physically engage in everyday moments – something many of us unintentionally take for granted.
By |2024-07-04T17:28:54+01:009 January 2024|Tech & industry|

Scientists unlock secrets of mutation of molecular anchor that can lead to ALS

Researchers have shed new light on the causes of ALS through an investigation of a molecular anchor called VAP (vesicle-associated membrane protein-associated protein).

When experiencing new things, the structure and function of our neurons and their connections are rapidly being remodeled. This process, known as synaptic plasticity, is critical for us to learn and adapt. However, these changes require a lot of energy. Fortunately, our neurons are well-adapted to support these changes. Biological batteries known as mitochondria are strategically stabilized near sites of synaptic remodeling to ensure a local and efficient energy supply. However, how mitochondria are anchored near synapses was not known. A team of scientists at Max Planck Florida Institute for Neuroscience has now identified a molecular anchor called VAP that stabilises mitochondria near synapses to support these remodeling projects. The identification of VAP as a molecular anchor has particular significance because a mutation in VAP leads to ALS (amyotrophic lateral sclerosis), a progressive motor neuroe degeneration disease. This discovery, published in Nature Communications, not only sheds light on how memories are powered but opens up new research directions into ALS pathology.
By |2026-09-28T21:37:37+01:008 January 2024|MND / ALS, Research, News, Researchers|

Milestone in exoskeleton’s US healthcare journey

News this week from the US health insurance world has provided encouragement for those pushing to increase access to rehab-based exoskeletons.

For the first time, Medicare, the US federal health insurance programme, has made a payment to rehab tech developer ReWalk for its wearable robotic device that allows paraplegics to walk again. The ReWalk Personal Exoskeleton enables powered hip and knee motion for people with a spinal cord injury (SCI), allowing them to stand upright, walk, turn, and climb up and down stairs. According to reports, the payment of US$94,617 to ReWalk was made via Medicare administrative contractor Noridian Healthcare Solutions. It could be a sign that the news represents recognition of exoskeletons as medically necessary for people with an SCI.
By |2026-09-28T21:37:37+01:008 January 2024|Spinal injury, Tech & industry, Smarter rehab|

A new tool in the fight to save brain injured babies

The development of a device which harnesses AI to detect brain injuries in newborn babies is speeding up thanks to a funding boost.

NeuroBell, an Irish university spinout has developed technology that enables real-time, accurate detection of seizures in newborn babies needing additional care. It uses artificial intelligence (AI) to help clinicians diagnose abnormal brain activity faster, enabling early intervention that can improve outcomes. NeuroBell was founded by Dr Mark O’Sullivan, Dr Alison O’Shea and Colm Murphy, and is a spin-out from University College Cork and the Irish Centre for Maternal and Child Health Research (Infant). It aims to address what the founders see as a critical gap in the availability and accuracy of current technologies used to detect seizures in newborns admitted to the neonatal intensive care unit (NICU).
By |2024-07-04T17:28:54+01:008 January 2024|Brain injury|
Go to Top